Hypolipidemic activity of boronated nucleosides and nucleotides in rodents.
Base-boronated nucleoside and phosphate-boronated nucleotides were potent hypolipidemic agents in rodents, lowering both serum cholesterol and triglyceride levels. Rat VLDL and LDL cholesterol levels were generally reduced and HDL cholesterol levels were significantly elevated after 14 days dosing at 8 mg/kg/day. Tissue cholesterol, triglyceride and phospholipid levels were reduced by selected derivatives. Increased fecal excretion of lipids did not appear to be a mechanism by which these derivatives lowered serum lipids in rodents. Rather, the agents suppressed appetite and reduced the activities of rate-limiting enzymes for de novo lipid synthesis, specifically cytoplasmic acetyl CoA synthetase, squalene synthetase, and phosphatidylate phosphohydrolase with IC50 values of approximately 10(-5) m.
Hall
I H
IH
Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360.
Burnham
B S
BS
Rajendran
K G
KG
Chen
S Y
SY
Sood
A
A
Spielvogel
B F
BF
Shaw
B R
BR
D000818:Animals; D001896:Boron Compounds / Q000494:pharmacology*; D008078:Cholesterol, LDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D000960:Hypolipidemic Agents; D051379:Mice; D008815:Mice, Inbred Strains; D009705:Nucleosides / Q000494:pharmacology*; D009711:Nucleotides / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012377:Rodentia
D001896:Boron Compounds; D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D000960:Hypolipidemic Agents; D009705:Nucleosides; D009711:Nucleotides